SOURCE: Frost & Sullivan

Frost & Sullivan

January 30, 2012 03:00 ET

Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility

Merck Serono Receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in Recognition of the Success of Its Comprehensive Portfolio of Hormone-Based Therapeutic Products and Strategic Expansion Across European and Global Infertility Treatment Markets

LONDON--(Marketwire - Jan 30, 2012) - Based on its recent analysis of the infertility therapeutics market, Frost & Sullivan recognizes Merck Serono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany, with the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership.

The European hormone products market for infertility has been relatively stagnant over a decade with less differentiation in terms of product characteristics and delivery mechanisms. Merck Serono, by virtue of its comprehensive range of innovative and unique products and advanced delivery systems aimed at improving therapeutic efficacy and patient compliance, has managed to stay ahead of its competitors in the European as well as global infertility therapeutics market.

Besides having one of the most varied product portfolios in the infertility therapeutics market, Merck Serono has been making substantial efforts to meet customers' needs." said Frost & Sullivan Research Analyst Aiswariya Chidambaram. "This is evident from the development of its new pre-filled, ready-to-use pen injectors for the administration of the three recombinant hormone products needed to treat infertility, which were recently approved by the Health Authorities."

"Additionally, the company has always been proactive in expanding its global footprint and exploring new market opportunities through strategic alliances with ideal partners in the pharmaceutical and biotechnology industries", remarks Chidambaram. "Similarly, Merck Serono has always remained pro-active in encouraging and nurturing innovation by funding innovative research projects and launching informative websites for the benefit of the patients."

Each year, Frost & Sullivan presents this award to the company whose competitive strategy yields significant gains in market share. The recognized company takes advantage of recent market changes that facilitate the introduction of novel methods of capturing and solidifying market presence. Alternatively, the award recipient has executed an innovative strategy within the existing competitive landscape. In either case, the company captures the attention of the competition, which quickly adjusts to protect its own market position. Frost & Sullivan analysts expect such innovations to produce lasting, precedent-setting trends in the industry.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Contact Information

  • Contact:

    Emily Bailey
    Promotions Coordinator
    Best Practices
    Frost & Sullivan
    emily.bailey@frost.com
    P: +44 (0)20 7915 7869